Blincyto(blinatumomab)
Blincyto 35 MCG Injection

Dosage & Administration

Dosage & Administration

drug label

Blincyto Prescribing Information

prior authorization

Blincyto Prior Authorization Resources

Most recent state uniform prior authorization forms

Verified: Jun 26, 2024Arizona - Uniform Prior Authorization Form
Verified: Jun 26, 2024Colorado - Uniform Prior Authorization Form
Verified: Jun 26, 2024Hawaii - Uniform Prior Authorization Form
Verified: Jul 26, 2024Illinois - Uniform Prior Authorization Form
Verified: Jun 26, 2024Indiana - Uniform Prior Authorization Form
Verified: Jun 26, 2024Louisiana - Uniform Prior Authorization Form
Verified: Jun 26, 2024Minnesota - Uniform Prior Authorization Form
Verified: Jun 26, 2024New Hampshire - Uniform Prior Authorization Form
Verified: Jun 26, 2024New Mexico - Uniform Prior Authorization Form
Verified: Jun 26, 2024Oregon - Uniform Prior Authorization Form
Verified: Jun 26, 2024Texas - Uniform Prior Authorization Form
Verified: Jul 07, 2024Washington - Uniform Prior Authorization Form
Verified: Jul 07, 2024Wisconsin - Uniform Prior Authorization Form
Complete Letter of Medical Necessity
Coverage Authorization Request
Coverage Authorization Appeals
Benefits Verification & PA Form

Benefits investigation

Benefits Verification & PA Form

Reimbursement help (FRM)

Receive Assistance from an FRM Regarding Reimbursement Information

financial assistance

Blincyto Financial Assistance Options

Copay savings program

Enroll in Patient Savings Program
Learn More

patient education

Blincyto Patient Education

To share resource; ask patient to:
1.Pull out phone
2.Open camera
3.Scan QR code with camera
4.Tap link

Patient toolkit

About Blincyto: Relapsed or Refractory CD19-positive B-cell Precursor ALL
ASK PATIENT TO:
Open Camera on Phone
Scan QR Code & Tap Link
About Blincyto (Pediatrics): Relapsed or Refractory CD19-positive B-cell Precursor ALL
ASK PATIENT TO:
Open Camera on Phone
Scan QR Code & Tap Link
Receiving Blincyto: Relapsed or Refractory CD19-positive B-cell Precursor ALL
ASK PATIENT TO:
Open Camera on Phone
Scan QR Code & Tap Link
About Blincyto: Minimal Residual Disease (+) ALL
ASK PATIENT TO:
Open Camera on Phone
Scan QR Code & Tap Link
About Blincyto (Pediatrics): Minimal Residual Disease (+) ALL
ASK PATIENT TO:
Open Camera on Phone
Scan QR Code & Tap Link
Receiving Treatment: Minimal Residual Disease (+) ALL
ASK PATIENT TO:
Open Camera on Phone
Scan QR Code & Tap Link
Patient Resources: Minimal Residual Disease (+) ALL
ASK PATIENT TO:
Open Camera on Phone
Scan QR Code & Tap Link
Patient Brochure : Minimal Residual Disease (+) ALL
ASK PATIENT TO:
Open Camera on Phone
Scan QR Code & Tap Link
Patient Brochure: Minimal Residual Disease (+) ALL - Spanish
ASK PATIENT TO:
Open Camera on Phone
Scan QR Code & Tap Link
Pediatric Patient Brochure: Minimal Residual Disease (+) ALL
ASK PATIENT TO:
Open Camera on Phone
Scan QR Code & Tap Link
Pediatric Patient Brochure: Minimal Residual Disease (+) ALL - Spanish
ASK PATIENT TO:
Open Camera on Phone
Scan QR Code & Tap Link
Medication Information Card: Minimal Residual Disease (+) ALL
ASK PATIENT TO:
Open Camera on Phone
Scan QR Code & Tap Link
Medical Information Card: Minimal Residual Disease (+) ALL - Spanish
ASK PATIENT TO:
Open Camera on Phone
Scan QR Code & Tap Link
Patient Resources: Relapsed or Refractory CD19-positive B-cell Precursor ALL
ASK PATIENT TO:
Open Camera on Phone
Scan QR Code & Tap Link
Patient Brochure: Relapsed or Refractory CD19-positive B-cell Precursor ALL
ASK PATIENT TO:
Open Camera on Phone
Scan QR Code & Tap Link
Patient Brochure: Relapsed or Refractory CD19-positive B-cell Precursor ALL - Spanish
ASK PATIENT TO:
Open Camera on Phone
Scan QR Code & Tap Link
Pediatric Patient Relapsed or Refractory CD19-positive B-cell Precursor ALL
ASK PATIENT TO:
Open Camera on Phone
Scan QR Code & Tap Link
Pediatric Patient Brochure: Relapsed or Refractory CD19-positive B-cell Precursor ALL - Spanish
ASK PATIENT TO:
Open Camera on Phone
Scan QR Code & Tap Link
Medical Information Card: Relapsed or Refractory CD19-positive B-cell Precursor ALL
ASK PATIENT TO:
Open Camera on Phone
Scan QR Code & Tap Link

people also ask

Blincyto FAQs

How is the dosage of Blincyto?Blincyto is available in 1 dosages, including 35 mcg Injection
What does Blincyto treat?Blincyto treats Lymphoid Leukemia
What is Blincyto made of?Blincyto contains blinatumomab which is a Bispecific CD19-directed CD3-directed T Cell Engager
How Is Blincyto Administered?Blincyto is administered as a Injectable
What Are The Blincyto Mechanism Of Action?Blincyto mechanism of action is CD19-directed Antibody Interactions, CD3 Receptor Agonists or CD3-directed Antibody Interactions
FAQ Data Source